NICOLINI GABRIELLA

Fermi, S., Malacrida, A., Molteni, L., Miloso, M., Cavaletti, G., Nicolini, G. (2025). Histone Deacetylase 6 Inhibitors: Mitigators Of Chemotherapy Induced Peripheral Neuropathy Via The NMNAT2/SARM1 Pathway Modulation. Intervento presentato a: 2025 PNS Annual Meeting, Edinburgh, Scotland. Detail

Sica, F., Patrucco, M., Giambra, M., Ghizzi, M., Sesana, S., Vergani, B., et al. (2025). Modulation of the blood–brain barrier permeability by patient-derived glioblastoma stem cell secretome. SCIENTIFIC REPORTS, 15(1) [10.1038/s41598-025-21272-3]. Detail

Fermi, S., Malacrida, A., Molteni, L., Miloso, M., Cavaletti, G., Nicolini, G. (2025). SARM1 modulation by HDAC6 inhibition as a neuroprotective strategy in chemotherapy-induced peripheral neuropathy. Intervento presentato a: NeuroMi 2025: Milan Center for Neuroscience, Milano, Italia. Detail

Fermi, S., Malacrida, A., Molteni, L., Tarasiuk, O., Miloso, M., Cavaletti, G., et al. (2024). Evaluation of Histone Deacetylase 6 inhibitors as possible neuroprotectors against Paclitaxel-induced peripheral neurotoxicity. In Abstracts of the Fourteenth Annual Meeting of the Associazione italiana per lo studio del Sistema Nervoso Periferico (ASNP), 30 May – 1 June 2024, Trieste, Italy. Detail

Rivara, M., Nicolini, G., Malacrida, A., Re, F., Incerti, M., Russo, G., et al. (2024). New ALKBH2 and ALKBH5 inhibitors for treating glioblastoma. RESULTS IN CHEMISTRY, 9(July 2024) [10.1016/j.rechem.2024.101645]. Detail